找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: 3D Printing; Emerging Technologie Michael A. Repka,Nigel Langley Book 2024 American Association of Pharmaceuticals Sciences 2024 3DP.biopri

[复制链接]
查看: 27979|回复: 50
发表于 2025-3-21 18:03:09 | 显示全部楼层 |阅读模式
期刊全称3D Printing
期刊简称Emerging Technologie
影响因子2023Michael A. Repka,Nigel Langley
视频video
发行地址Covers regulatory and manufacturing aspects of 3D printing in drug development.Particular focus on hot melt extrusion and extruded filaments suitable for optimizing 3D printing.Thorough short text and
学科分类AAPS Advances in the Pharmaceutical Sciences Series
图书封面Titlebook: 3D Printing; Emerging Technologie Michael A. Repka,Nigel Langley Book 2024 American Association of Pharmaceuticals Sciences 2024 3DP.biopri
影响因子This inclusive text describes .3D Printing. for pharmaceutical applications, including emerging 3D technologies. The book focuses on the functionality of the materials/biomaterials used for the preparation of dosage forms and devices, fundamentals for preparing these systems and novel applications using these additive manufacturing techniques.  Also, the text includes clinical relevance and regulatory considerations for the future of personalized medicine..Authored by experts with a broad range of experience, extensive insight into the science of .3D printing. technology used to produce these systems is provided.  Highlighting viewpoints from the academic, polymer excipient, equipment, product development and regulatory communities, this comprehensive text compiles input from industry thought leaders to illustrate strategies and technologies for applying techniques of additive manufacturing for drug product and device development whilealso providing insight into the path forward for the technology in years to come.  .
Pindex Book 2024
The information of publication is updating

书目名称3D Printing影响因子(影响力)




书目名称3D Printing影响因子(影响力)学科排名




书目名称3D Printing网络公开度




书目名称3D Printing网络公开度学科排名




书目名称3D Printing被引频次




书目名称3D Printing被引频次学科排名




书目名称3D Printing年度引用




书目名称3D Printing年度引用学科排名




书目名称3D Printing读者反馈




书目名称3D Printing读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:01:27 | 显示全部楼层
Geburt, Tod und Wanderbewegungenluding powder-based, extrusion-based and photopolymerisation methods, this review highlights the distinctive attributes, advantages and challenges associated with each technique. It delves into their applications in drug formulation, personalised medicine and dosage form customisation. As can be see
发表于 2025-3-22 01:20:32 | 显示全部楼层
发表于 2025-3-22 04:56:05 | 显示全部楼层
https://doi.org/10.1007/978-3-662-50508-3rug products. With the advent of 3D printing in pharmaceutical manufacturing, the ability to create intricate dosage forms and personalized medications has introduced new opportunities and challenges. Effective QC strategies encompass material selection, process validation, and post-processing steps
发表于 2025-3-22 12:18:53 | 显示全部楼层
https://doi.org/10.1007/978-3-662-52768-9 deposition modeling (FDM) 3D printing. The polymers used for hot melt extrusion (HME) theoretically can be utilized for FDM 3D printing. However, the melt viscosity should be carefully considered as 3D printing is more limited by the printers where the printing tip orifice size is usually small. Pl
发表于 2025-3-22 16:15:20 | 显示全部楼层
Musterlösungen zu ausgewählten Aufgabenntial material properties. Highlighting the significance of material selection in achieving successful printing outcomes, the review discusses the interplay between polymer characteristics such as rheology, viscosity, and molecular weight and their impact on printability, including novel polymers. B
发表于 2025-3-22 17:58:19 | 显示全部楼层
发表于 2025-3-23 00:17:57 | 显示全部楼层
https://doi.org/10.1007/978-3-662-52911-9icals. In 2015 the approval of the first 3D-printed product SPRITRAM. (levetiracetam) by the US Food and Drug Administration (USFDA) attracted researchers from various avenues of the pharmaceutical sector. The orally disintegrating levetiracetam tablets are manufactured by Aprecia Pharmaceuticals (O
发表于 2025-3-23 02:53:12 | 显示全部楼层
发表于 2025-3-23 09:17:03 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 23:41
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表